Ionis cuts Tryngolza 2026 sales guidance, highlights Zanvastro launch and new Phase 3 winsNov 9Quarterly updateIonis PharmaceuticalsolezarsenUpdated
Amarin posts first profitable quarter in two years as VAZKEPA growth accelerates in EuropeOct 28Quarterly updateAmarin Corp Plc\Uk
Sign in